Abbott Posts Slight Q3 Beat, Narrows Outlook

By: via Benzinga
Abbott Laboratories (NYSE: ABT) suffered a net loss in the third quarter to reflect adjustment of its equity investment in Mylan NV ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.